fbpx

Archive: April 9, 2021

(Reuters) -The U.S. National Institutes of Health said on Wednesday it had begun a mid-stage study to determine the risk of allergic reactions …

Read More

Merck & Co. announced Thursday that a Phase III study of Keytruda (pembrolizumab) as adjuvant therapy in patients with renal cell carcinoma (RCC) …

Read More

FOSTER CITY, Calif.–(BUSINESS WIRE)– Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval …

Read More

RALEIGH, N.C. (AP) — North Carolina health officials said on Thursday that they stopped administering Johnson & Johnson doses at a mass vaccination …

Read More

X
Send a message
Request a call

    * Required fields

    By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.

      * Required fields

      By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.

      X